Separation methods that are capable of revealing blood-brain barrier permeability

被引:24
作者
Dash, AK
Elmquist, WF
机构
[1] Creighton Univ, Med Ctr, Sch Pharm & Hlth Profess, Dept Pharm Sci, Omaha, NE 68178 USA
[2] Univ Minnesota, Dept Pharmaceut, Coll Pharm, Minneapolis, MN 55455 USA
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2003年 / 797卷 / 1-2期
关键词
reviews; blood-brain barrier;
D O I
10.1016/S1570-0232(03)00605-6
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The objective of this review is to emphasize the application of separation science in evaluating the blood-brain barrier (BBB) permeability to drugs and bioactive agents. Several techniques have been utilized to quantitate the BBB permeability. These methods can be classified into two major categories: in vitro or in vivo. The in vivo methods used include brain homogenization, cerebrospinal fluid (CSF) sampling, voltametry, autoradiography, nuclear magnetic resonance (NMR) spectroscopy, positron emission tomography (PET), intracerebral microdialysis, and brain uptake index (BUI) determination. The in vitro methods include tissue culture and immobilized artificial membrane (LAM) technology. Separation methods have always played an important role as adjunct methods to the methods outlined above for the quantitation of BBB permeability and have been utilized the most with brain homogenization, in situ brain perfusion, CSF sampling, intracerebral microdialysis, in vitro tissue culture and IAM chromatography. However, the literature published to date indicates that the separation method has been used the most in conjunction with intracerebral microdialysis and CSF sampling methods. The major advantages of microdialysis sampling in BBB permeability studies is the possibility of online separation and quantitation as well as the need for only a small sample volume for such an analysis. Separation methods are preferred over non-separation methods in BBB permeability evaluation for two main reasons. First, when the selectivity of a determination method is insufficient, interfering substances must be separated from the analyte of interest prior to determination. Secondly, when large number of analytes is to be detected and quantitated by a single analytical procedure, the mixture must be separated to each individual component prior to determination. Chiral separation in particular can be essential to evaluate the stereo-selective permeation and distribution of agents into the brain. In conclusion, the usefulness of separation methods during BBB permeability evaluation is immense and more application of these methods is foreseen in the future. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:241 / 254
页数:14
相关论文
共 105 条
[61]   Simple liquid chromatographic method for the analysis of the blood brain barrier permeability characteristics of ceftriaxone in an experimental rabbit meningitis model [J].
Owens, HM ;
Destache, CJ ;
Dash, AK .
JOURNAL OF CHROMATOGRAPHY B, 1999, 728 (01) :97-105
[62]   Blood-brain barrier biology and methodology [J].
Pardridge, WM .
JOURNAL OF NEUROVIROLOGY, 1999, 5 (06) :556-569
[63]   RAPID SEQUESTRATION AND DEGRADATION OF SOMATOSTATIN ANALOGS BY ISOLATED BRAIN MICROVESSELS [J].
PARDRIDGE, WM ;
EISENBERG, J ;
YAMADA, T .
JOURNAL OF NEUROCHEMISTRY, 1985, 44 (04) :1178-1184
[64]   Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids [J].
Pardridge, WM .
NEUROCHEMICAL RESEARCH, 1998, 23 (05) :635-644
[65]   TRANSPORT OF HUMAN RECOMBINANT BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) THROUGH THE RAT BLOOD-BRAIN-BARRIER IN-VIVO USING VECTOR-MEDIATED PEPTIDE DRUG-DELIVERY [J].
PARDRIDGE, WM ;
KANG, YS ;
BUCIAK, JL .
PHARMACEUTICAL RESEARCH, 1994, 11 (05) :738-746
[66]   TRANSPORT OF SMALL MOLECULES THROUGH THE BLOOD-BRAIN-BARRIER - BIOLOGY AND METHODOLOGY [J].
PARDRIDGE, WM .
ADVANCED DRUG DELIVERY REVIEWS, 1995, 15 (1-3) :5-36
[67]   Capillary electrophoresis in clinical chemistry [J].
Perrett, D .
ANNALS OF CLINICAL BIOCHEMISTRY, 1999, 36 :133-150
[68]   IAM CHROMATOGRAPHY - AN IN-VITRO SCREEN FOR PREDICTING DRUG MEMBRANE-PERMEABILITY [J].
PIDGEON, C ;
ONG, SW ;
LIU, HL ;
QIU, XX ;
PIDGEON, M ;
DANTZIG, AH ;
MUNROE, J ;
HORNBACK, WJ ;
KASHER, JS ;
GLUNZ, L ;
SZCZERBA, T .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (04) :590-594
[69]   Monitoring γ-aminobutyric acid in-human brain and plasma microdialysates using micellar electrokinetic chromatography and laser-induced fluorescence detection [J].
Rada, P ;
Tucci, S ;
Teneud, L ;
Paez, X ;
Alba, G ;
García, Y ;
Sacchettoni, S ;
del Corral, J ;
Hernandez, L .
JOURNAL OF CHROMATOGRAPHY B, 1999, 735 (01) :1-10
[70]   DRUG ENTRY INTO THE BRAIN [J].
RAPOPORT, SI ;
OHNO, K ;
PETTIGREW, KD .
BRAIN RESEARCH, 1979, 172 (02) :354-359